|
|
|
Volumn 5, Issue 3, 1999, Pages 159-175
|
|
Debates in hepatitis: How to assess HBV DNA reductions in association with therapy
a
a
|
|
Author keywords
HBeAg seroconversion; HBV DNA; Interferon ; Lamivudine
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
IODINE 125;
LAMIVUDINE;
VIRUS DNA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
MAJOR CLINICAL STUDY;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SEROCONVERSION;
SHORT SURVEY;
VIRUS DETECTION;
VIRUS HEPATITIS;
|
|
EID: 0032859508
PISSN: 10817050
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (14)
|
|
References (66)
|
